MedPath
HSA Approval

MICROGYNON 30 TABLET

SIN04834P

MICROGYNON 30 TABLET

MICROGYNON 30 TABLET

June 26, 1990

BAYER (SOUTH EAST ASIA) PTE LTD

BAYER (SOUTH EAST ASIA) PTE LTD

Regulatory Information

BAYER (SOUTH EAST ASIA) PTE LTD

BAYER (SOUTH EAST ASIA) PTE LTD

Therapeutic

Prescription Only

Formulation Information

TABLET, SUGAR COATED

ORAL

Medical Information

G03AA07

levonorgestrel and ethinylestradiol

Manufacturer Information

BAYER (SOUTH EAST ASIA) PTE LTD

BAYER WEIMAR GMBH UND CO. KG

Active Ingredients

ETHINYLESTRADIOL

0.03 mg

Ethinylestradiol

LEVONORGESTREL

0.15 mg

Levonorgestrel

Documents

Package Inserts

MICROGYNON 30 TABLET PI.pdf

Approved: March 22, 2022

Download
© Copyright 2025. All Rights Reserved by MedPath